The landscape of dementia prognosis has developed dramatically with the arrival of complex biomarkers, such as amyloid PET scans, tau imaging, and blood-based mostly assessments that can detect Alzheimer's pathology many years ahead of indications emerge. Although these technological improvements depict extraordinary development in comprehending ne